| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.02 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |